Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J P, Perras"'
Review of data on gynecologic cancer cell lines: potential applications of ATP-cell viability assays
Publikováno v:
Contributions to gynecology and obstetrics. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37eb458c7d288b50718c91b67d5ca239
https://pubmed.ncbi.nlm.nih.gov/7995045
https://pubmed.ncbi.nlm.nih.gov/7995045
Autor:
J P, Perras, J, Hurst
Publikováno v:
Contributions to gynecology and obstetrics. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6a1c1f418a3282e41e577ffbe514fbb
https://pubmed.ncbi.nlm.nih.gov/7995044
https://pubmed.ncbi.nlm.nih.gov/7995044
Publikováno v:
Contributions to gynecology and obstetrics. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f7e758e957dfb1e328a4cb7a250d6e7
https://pubmed.ncbi.nlm.nih.gov/7995049
https://pubmed.ncbi.nlm.nih.gov/7995049
Publikováno v:
Contributions to gynecology and obstetrics. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c44c5b0d0d638ede6708014cfa3beb8e
https://pubmed.ncbi.nlm.nih.gov/7995042
https://pubmed.ncbi.nlm.nih.gov/7995042
Autor:
R, Angioli, B U, Sevin, J P, Perras, M, Untch, O R, Koechli, H N, Nguyen, A, Steren, J G, Schwade, C, Villani, H E, Averette
Publikováno v:
Cancer. 71(11)
This investigation, which evaluates the combination of radiation and interferon, bridges two clinical treatments of cancer. Radiation therapy (RT) is an integral part of cervical cancer treatment; interferons (IFN), however, are classified as modifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ac58cc7d096202d2c1c5161684064833
https://pubmed.ncbi.nlm.nih.gov/8490922
https://pubmed.ncbi.nlm.nih.gov/8490922
Autor:
R, Angioli, M, Untch, B U, Sevin, A, Steren, R D, Hightower, J P, Perras, H N, Nguyen, O R, Koechli, H E, Averette
Publikováno v:
Cancer. 71(9)
Interferon (IFN) has been reported to increase hormone receptor expression in breast cancer cells and to sensitize them to antiproliferative hormones. Endometrial cancer cells with high progesterone receptor (PR) level respond better to progesterone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9dee9ba7ba99e9f6b086ed52c97ea4bf
https://pubmed.ncbi.nlm.nih.gov/8467457
https://pubmed.ncbi.nlm.nih.gov/8467457
Publikováno v:
Cancer. 71
Most patients with ovarian cancer currently are treated primarily with surgery and chemotherapy. Drug selection usually is not based on individualized in vitro sensitivity studies but on reported response rates of clinical trials. Attempts to include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::716fd6679816f2597db987807aa397d3
https://pubmed.ncbi.nlm.nih.gov/8431897
https://pubmed.ncbi.nlm.nih.gov/8431897
Publikováno v:
Gynecologic oncology. 38(2)
The monitoring value of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--alone and in combination has been studied in 152 patients with invasive, epithelial ovarian cancer. The sensitivity and specificity of CA-125 (90 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::50a171cf4c9e023381d5661aba616df5
https://pubmed.ncbi.nlm.nih.gov/2387533
https://pubmed.ncbi.nlm.nih.gov/2387533